RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection

被引:146
作者
Vigne, E [1 ]
Mahfouz, I [1 ]
Dedieu, JF [1 ]
Brie, A [1 ]
Perricaudet, M [1 ]
Yeh, P [1 ]
机构
[1] Inst Gustave Roussy, CNRS UMR 1582, IGR, Rhone Poulenc Rorer, F-94805 Villejuif, France
关键词
D O I
10.1128/JVI.73.6.5156-5161.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hypervariable region 5 (HVR5) is a hydrophilic, serotypically nonconserved loop of the hexon monomer which extrudes from the adenovirus (Ad) capsid. We have replaced the HVR5 sequence of Ad5 with that of heterologous peptides and studied their effects on virus viability. and peptide accessibility. A poliovirus model epitope was first inserted in a series of nine "isogenic",viruses that differed in their flanking spacers. Whereas virus productivity was not profoundly altered by any of these modifications, immunoprecipitation experiments under nondenaturing conditions demonstrated that epitope recognition by its cognate monoclonal antibody (C3 MAb) was strongly linker dependent and correlated perfectly with the ability of C3 MAb to inhibit transgene delivery and expression. An alpha(v)-specific ligand (DCRGDCF) was then inserted in a suitable linker context to investigate whether hexon-modified capsids,would enhance the transduction of cells displaying limiting amounts of the virus attachment receptors. Interestingly, although hexon has never been implicated in Ad entry, the modified virus significantly increased the transduction of human vascular smooth muscle cells in vitro. Competition experiments with 293 cells saturated with recombinant knob further indicated that the hexon-modified virus could use an additional, knob-independent pathway for entry. We concluded that genetic engineering of the Ad5 hexon monomer constitutes a novel and feasible approach to equip the virus with additional targeting ligands.
引用
收藏
页码:5156 / 5161
页数:6
相关论文
共 28 条
[1]   THE REFINED CRYSTAL-STRUCTURE OF HEXON, THE MAJOR COAT PROTEIN OF ADENOVIRUS TYPE-2, AT 2-CENTER-DOT-9 ANGSTROM RESOLUTION [J].
ATHAPPILLY, FK ;
MURALI, R ;
RUX, JJ ;
CAI, ZP ;
BURNETT, RM .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 242 (04) :430-455
[2]   Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5 [J].
Bergelson, JM ;
Cunningham, JA ;
Droguett, G ;
KurtJones, EA ;
Krithivas, A ;
Hong, JS ;
Horwitz, MS ;
Crowell, RL ;
Finberg, RW .
SCIENCE, 1997, 275 (5304) :1320-1323
[3]  
BLANCHE F, COMMUNICATION
[4]   Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma [J].
Clayman, GL ;
El-Naggar, AK ;
Lippman, SM ;
Henderson, YC ;
Frederick, M ;
Merritt, JA ;
Zumstein, LA ;
Timmons, TM ;
Liu, TJ ;
Ginsberg, L ;
Roth, JA ;
Hong, WK ;
Bruso, P ;
Goepfert, H .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2221-2232
[5]   EXPRESSION OF A FOREIGN EPITOPE ON THE SURFACE OF THE ADENOVIRUS HEXON [J].
CROMPTON, J ;
TOOGOOD, CIA ;
WALLIS, N ;
HAY, RT .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :133-139
[6]  
Crouzet J, 1997, P NATL ACAD SCI USA, V94, P1414, DOI 10.1073/pnas.94.4.1414
[7]  
DEDIEU JF, UNPUB
[8]   Targeted gene delivery by tropism-modified adenoviral vectors [J].
Douglas, JT ;
Rogers, BE ;
Rosenfeld, ME ;
Michael, SI ;
Feng, MZ ;
Curiel, DT .
NATURE BIOTECHNOLOGY, 1996, 14 (11) :1574-1578
[9]  
Gahéry-Ségard H, 1998, J VIROL, V72, P2388
[10]   Adenovirus type 5 and 7 capsid chimera: Fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes [J].
Gall, J ;
KassEisler, A ;
Leinwand, L ;
FalckPedersen, E .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2116-2123